Acta Anaesthesiol Scand
- ROMUNDSTAD L, Raeder J
Does methadone offer any benefits for analgesia over morphine after bladder
cancer surgery?
Acta Anaesthesiol Scand. 2025;69:e14552.
Adv Sci (Weinh)
- DAN W, Fan Y, Wang Y, Hou T, et al
The Tumor Suppressor TPD52-Governed Endoplasmic Reticulum Stress is Modulated by
APC(Cdc20).
Adv Sci (Weinh). 2024;11:e2405441.
Anticancer Res
- JARADAT JH, Idrissi YA, Saeed A
HOOK3 Amplification in Bladder Urothelial Carcinoma: Insights from Gene
Expression and Survival Analysis.
Anticancer Res. 2024;44:5175-5185.
Asian J Surg
- WU L, Yang E, Zhang Y, Yin B, et al
An immune-related lncRNA signature for predicting overall survival and
chemotherapy sensitivity in bladder cancer patients.
Asian J Surg. 2024 Nov 29:S1015-9584(24)02515.
BJU Int
- AKDEMIR E, Stuiver MM, van de Kamp MW, der Hulst JB, et al
Long-term quality of life in patients with bladder cancer following radical
cystectomy.
BJU Int. 2024 Dec 1. doi: 10.1111/bju.16610.
Cancer Med
- DALL CP, Liu X, Faraj KS, Srivastava A, et al
Hospital Quality and Racial Differences in Outcomes After Genitourinary Cancer
Surgery.
Cancer Med. 2024;13:e70436.
Clin Cancer Res
- FLECHON A, Morales-Barrera R, Powles T, Alva A, et al
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of
Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced
Urothelial Carcinoma.
Clin Cancer Res. 2024;30:5353-5364.
Clin Genitourin Cancer
- MALSHY K, Steidle M, Tabayoyong W, Messing EM, et al
Letter to the Editor: Risk of Metachronous Upper Tract Urothelial Carcinoma After
Ureteral Stenting in Patients With Bladder Cancer.
Clin Genitourin Cancer. 2024;23:102263.
Discov Oncol
- CAO N, Cheng F, Zhou J, Liu N, et al
Identification and construction of prognostic clusters and risk-prognosis model
based on aging-immune related genes in bladder cancer.
Discov Oncol. 2024;15:742.
Einstein (Sao Paulo)
- DE SOUSA NETO PI, Pinto VBP, Pianco EDS, Gomes ML, et al
The role of microRNAs in non-invasive diagnosis of bladder cancer: a systematic
review.
Einstein (Sao Paulo). 2024;22:eRW0611.
ESMO Open
- MYERS AA, Fang AM, Moussa MJ, Hwang H, et al
Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of
the bladder.
ESMO Open. 2024;9:103964.
Eur J Cell Biol
- HUANG SY, Yu TS, Lin JH, Liu WH, et al
Stable laminar shear stress induces G1 cell cycle arrest and autophagy in
urothelial carcinoma by a torque sensor-coupled cone-and-plate device.
Eur J Cell Biol. 2024;103:151451.
Fr J Urol
- PALKOWSKI T, Bibeau F, Thiery-Vuillemin A, Kleinclauss F, et al
High-Risk Non-Muscle Invasive Bladder Cancer: outcomes of patients who cannot
benefit from Standard of Care.
Fr J Urol. 2024 Dec 3:102838. doi: 10.1016/j.fjurol.2024.102838.
Front Immunol
- ZOU J, Xu B, Luo P, Chen T, et al
Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?
Front Immunol. 2024;15:1482765.
Hinyokika Kiyo
- NISHIMURA Y, Oki Y, Nonomura D, Matsuzaki K, et al
[A Case of Secondary Extramammary Paget's Disease Developed at 11 Years after
Cystectomy].
Hinyokika Kiyo. 2024;70:335-341.
- NARA T, Numakura K, Kikuchi A, Sekine Y, et al
[Four Cases of Bladder Cancer in Young Patients with Severe Motor and
Intellectual Disabilities].
Hinyokika Kiyo. 2024;70:227-231.
Hum Cell
- LIU B, Chen M, Liang Y, Mei Z, et al
ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification
of PJA2 and ubiquitination of KSR1.
Hum Cell. 2024;38:23.
Int J Med Sci
- YANG X, Zheng H, Huang J, Liu Y, et al
Co-inhibition of PGF and VEGFA enhances the effectiveness of immunotherapy in
bladder cancer.
Int J Med Sci. 2024;21:2870-2882.
Int J Urol
- PALERMO G, Bizzarri FP, Scarciglia E, Sacco E, et al
The mental and emotional status after radical cystectomy and different urinary
diversion orthotopic bladder substitution versus external urinary diversion after
radical cystectomy: A propensity score-matched study.
Int J Urol. 2024;31:1423-1428.
- SASAKI Y, Fukuta K, Kadoriku F, Daizumoto K, et al
Retroperitoneal cutaneous ureterostomy following radical cystectomy: A
multicenter comparative study of robotic versus open surgery.
Int J Urol. 2024;31:1408-1413.
- MORIZANE S, Miki J, Shimbo M, Kanno T, et al
Japanese expert consensus on the standardization of robot-assisted pelvic lymph
node dissection in urological surgery: Extent of pelvic lymph node and surgical
technique.
Int J Urol. 2024;31:1300-1310.
J Cell Biochem
-
RETRACTION: Upregulation of LncRNA SnoRNA Host Gene 6 Regulates NUAK Family
SnF1-like Kinase-1 Expression by Competitively Binding MicroRNA-125b and
Interacting with Snail1/2 in Bladder Cancer.
J Cell Biochem. 2024 Dec 1:e30676. doi: 10.1002/jcb.30676.
J Clin Invest
- SADHUKHAN P, Feng M, Illingworth EJ, Sloma I, et al
YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/
STAT3 pathway and CXCL deregulation.
J Clin Invest. 2024 Nov 21:e171164. doi: 10.1172/JCI171164.
JCO Precis Oncol
- CRUPI E, Costa de Padua T, Marandino L, Fallara G, et al
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.
JCO Precis Oncol. 2024;8:e2400470.
Minerva Urol Nephrol
- FERRO M, Tataru OS, Fallara G, Fiori C, et al
Assessing the influence of smoking on inflammatory markers in bacillus Calmette
Guerin response among bladder cancer patients: a novel machine-learning approach.
Minerva Urol Nephrol. 2024 Dec 3. doi: 10.23736/S2724-6051.24.05876.
Nan Fang Yi Ke Da Xue Xue Bao
- LI L, Guo Y, Wang C, Chang R, et al
[High expression of miR-204-5p promotes malignant behaviors of bladder cancer
cells by negatively regulating RAB22A].
Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:2235-2242.
Nat Biomed Eng
-
A two-phase point-of-care diagnostic device for bladder cancer.
Nat Biomed Eng. 2024 Dec 2. doi: 10.1038/s41551-024-01301.
Nat Commun
- TUCCI FA, Pennisi R, Rigiracciolo DC, Filippone MG, et al
Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis.
Nat Commun. 2024;15:10378.
Nat Prod Res
- SILVEIRA BM, Amparo TR, Seibert JB, Almeida TC, et al
Hydromethanolic fraction from Abatia americana (Salicaceae) inhibits T24 bladder
cancer cell line and the bacterium Listeria monocytogenes with high selectivity.
Nat Prod Res. 2024 Dec 5:1-5. doi: 10.1080/14786419.2024.2435536.
PeerJ
- ZHANG Z, Liu F, Yu Y, Xie F, et al
Prognosis and immune landscape of bladder cancer can be predicted using a novel
miRNA signature associated with cuproptosis.
PeerJ. 2024;12:e18530.
Sci Rep
- HU HY, Hu SY, Yang M, Hu Y, et al
Hu similarity coefficient: a clinically oriented metric to evaluate contour
accuracy in radiation therapy.
Sci Rep. 2024;14:30215.
Stem Cells Int
- YANG E, Ji L, Zhang X, Jing S, et al
Identification of a Novel Mesenchymal Stem Cell-Related Signature for Predicting
the Prognosis and Therapeutic Responses of Bladder Cancer.
Stem Cells Int. 2024;2024:6064671.
Toxicol In Vitro
- TERZI E, Oz-Bedir BE, Ercan E, Ozdemir-Sanci T, et al
beta-Arbutin and cisplatin: A combined approach to modulating apoptosis, cell
viability, and migration in bladder cancer cells.
Toxicol In Vitro. 2024 Dec 3:105985. doi: 10.1016/j.tiv.2024.105985.
Urol Int
- CHEN H, Wu M, Chen M
Evaluation of the Management of Urachal Carcinoma: A Single-Center Experience
over 13 Years.
Urol Int. 2024;108:508-516.
Urology
- ECKE TH, Meisl CJ, Schlomm T, Rabien A, et al
Performance of urinary markers in patients with suspicious cystoscopy during
follow-up of recurrent non-muscle invasive bladder cancer: BTA stat(R), NMP22(R)
BladderChek(R), UBC(R) Rapid Test, CancerCheck(R) UBC(R) rapid VISUAL, and uromonitor(R) in
c
Urology. 2024 Dec 1:S0090-4295(24)01113-0. doi: 10.1016/j.urology.2024.
World J Urol
- CAMPBELL T, Hunt TC, Li A, Cheng Z, et al
Analysis of Genitourinary Rhabdomyosarcoma in Phase 3 clinical trials.
World J Urol. 2024;43:6.
- GABRIEL PE, Ganesan V, Krishnan J, Autorino R, et al
Pure open versus robotic radical cystectomy with intracorporeal urinary
diversion: a propensity matched analysis.
World J Urol. 2024;43:13.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016